Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Blank Control, Multicenter Study to Evaluate the Efficacy and Safety of Alanine Aminotransferase（TMF）in the Treatment of Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.

NCT05797714 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05797714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Blank Control, Multicenter Study to Evaluate the Efficacy and Safety of Alanine Aminotransferase（TMF）in the Treatment of Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 8, 2022
Completion date
April 30, 2028
Enrollment
200 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, hbv infection